Enovis Corporation
ENOVNYSEHealthcare● Active
$23.78
+$0.92(+4.02%)
Market Cap$1.4B
P/E Ratio—
52W High$36.82
52W Low$20.82
Enovis Corporation (ENOV) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ENOV · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.25B | $2.11B | $1.71B | $1.56B | $1.43B |
| Cost of Revenue | $0.90B | $0.93B | $0.72B | $0.69B | $0.65B |
| Gross Profit | $1.35B | $1.18B | $0.99B | $0.87B | $0.78B |
| Gross Margin %(computed) | 59.84% | 56.02% | 58.04% | 55.62% | 54.53% |
| Operating Expenses | |||||
| R&D Expenses | $0.12B | $0.09B | $0.08B | $0.06B | $0.05B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $1.36B | $1.96B | $1.06B | $0.94B | $0.84B |
| Operating Income | ($0.02B) | ($0.78B) | ($0.07B) | ($0.07B) | ($0.06B) |
| Operating Margin %(computed) | -0.84% | -36.81% | -3.85% | -4.55% | -4.40% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.03B | $0.06B | $0.02B | $0.02B | $0.03B |
| Income Before Tax | ($1.16B) | ($0.82B) | ($0.07B) | ($0.00B) | ($0.12B) |
| Income Tax Expense | $0.02B | $0.00B | ($0.01B) | $0.04B | ($0.02B) |
| Net Income | ($1.18B) | ($0.83B) | ($0.03B) | ($0.01B) | $0.07B |
| Net Margin %(computed) | -52.69% | -39.17% | -1.95% | -0.85% | 5.02% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-20.86 | $-14.93 | $-0.61 | $-0.28 | $-2.02 |
| Wtd Avg Shares | 0.06B | 0.06B | 0.05B | 0.05B | 0.05B |
| EBITDA | ($0.83B) | ($0.48B) | $0.17B | $0.24B | $0.17B |
| EBITDA Margin %(computed) | -36.93% | -22.82% | 9.94% | 15.46% | 11.94% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Enovis Corporation data
About Enovis Corporation (ENOV) Income Statement
Enovis Corporation (ENOV) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ENOV reported revenue of $2.25B, gross profit of $1.35B (gross margin 59.84%), and net income of ($1.18B) — a net profit margin of -52.69%.
Frequently asked questions
ENOV · 4 questionsEnovis Corporation (ENOV) reported revenue of $2.25B for 2025, up 6.7% year-over-year.
ENOV revenueENOV salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08